Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Consolidated Statements of Operations and Comprehensive Loss

v3.19.3.a.u2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenue (note 10)    
Licensing revenue $ 318 $ 118
Contract revenue 0 345
Revenue 318 463
Expenses    
Research and development (note 15) 52,866 41,382
Corporate, administration and business development (note 15) 22,154 13,674
Amortization of acquired intellectual property and other intangible assets (note 7) 1,389 1,545
Amortization of property and equipment (note 6) 159 20
Other expenses (note 16) 8,991 169
Expenses 85,559 56,790
Loss before interest income, finance costs, change in estimated fair value of derivative warrant liabilities and income taxes (85,241) (56,327)
Interest income 2,702 2,234
Finance costs (note 16) (39) 0
Loss before change in estimated fair value of derivate warrant liabilities and income taxes (82,578) (54,093)
Change in estimated fair value of derivative warrant liabilities (note 13) (41,124) (9,954)
Loss before income taxes (123,702) (64,047)
Income tax expense (note 17) 144 73
Net loss and comprehensive loss for the year $ (123,846) $ (64,120)
Basic and diluted loss per common share (in dollars per share) $ (1.33) $ (0.76)